Duchesnay Flagged for Omitting Risks of Morning Sickness Drug

Washington Drug Letter
Shortly after Duchesnay received FDA approval for its morning sickness drug Diclegis, the agency says the Canadian drugmaker sent a letter to customers touting the drug’s benefits but none of its risks.

To View This Article:


Buy This Article Now

Add this article to your cart for $25.00